| Date | Target |
Transaction Type Value: $mlns |
Acquirer | Seller | ||
|---|---|---|---|---|---|---|
| 2017-12-21 |
Bio Palette
Life Science Kobe, Japan www.biopalette.co.jp Bio Palette is a operator of a platform intended to offer gene-editing techniques. Bio Palette plans to develop business in three fields, classified based on the type of cells targeted for genome editing. Bio Palette was founded in 2017 and is based in Kobe, Japan. |
Venture |
Eight Roads
|
- | ||
| 2017-12-18 |
Base Pair Biotechnologies
Life Science Houston, Texas www.basepairbio.com Base Pair Biotechnologies is a provider of highly customized aptamer discovery and development services. Base Pair Biotechnologies was founded in 2012 and is based in Houston, Texas. |
Venture |
Eventi Capital Partners
|
- | ||
| Deal Article Deal Link | ||||||
| 2017-12-14 |
Ginkgo Bioworks
Life Science Boston, Massachusetts www.ginkgo.bio Ginkgo Bioworks is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks was established in 2008 and is based in Boston, Massachusetts. |
Venture |
General Atlantic
|
- | ||
| Deal Article Deal Link | ||||||
| 2017-12-14 |
Jnana Therapeutics
Life Science Boston, Massachusetts www.jnanatx.com Jnana Therapeutics is developing drugs against a broad family of metabolite transport proteins to treat high unmet needs in auto-immune, immuno-metabolism, and other diseases. Jnana Therapeutics was founded in 2017 and is based in Boston, Massachuserrs. |
Venture |
Polaris Partners
|
- | ||
| Deal Article Deal Link | ||||||
| 2017-12-11 |
Aelin Therapeutics
Life Science Leuven, Belgium www.aelintx.com Aelin Therapeutics is pioneering a novel modality in drug development in order to create a completely new class of antibiotics and first-in-class therapeutics against high-value undruggable human targets. The technology, branded Pept-ins™ harnesses the power of protein aggregation to specifically induce functional knockdown of a target protein. Aelin Therapeutics is based in Leuven, Belgium. |
Venture |
EQT Life Sciences
|
- | ||
| Deal Article Deal Link | ||||||
| 2017-12-11 |
Hookipa
Life Science New York, New York www.hookipapharma.com Hookipa is a clinical stage biotech company aiming to develop best-in-class active immunization therapies for infectious diseases and oncology. Hookipa was founded in 2011 and is based in New York, New York. |
Venture |
HBM Partners
|
- | ||
| Deal Article Deal Link | ||||||
| 2017-11-30 |
Semma Therapeutics
Life Science Cambridge, Massachusetts www.semma-tx.com Semma Therapeutics is a privately held biotechnology company pioneering the use of stem cell-derived human islets as a potentially curative treatment for type 1 diabetes. Semma Therapeutics was formed in 2015 and is based in Cambridge, Massachusetts. |
Venture |
Eight Roads
|
- | ||
| 2017-11-28 |
IsoPlexis
Life Science Branford, Connecticut www.isoplexis.com IsoPlexis is a life sciences company developing a diagnostic platform that identifies a wide range of patient immune responses at the cellular level. Its platform can assess safety and efficacy of therapeutics and monitor disease progression, enabling improved therapeutic development and informing physician decisions. IsoPlexis was founded in 2013 and is based in Branford, Connecticut. |
Venture |
Ironwood Capital
Advantage Capital Partners
|
- | ||
| Deal Article Deal Link | ||||||
| 2017-11-28 |
NanoCellect Biomedical
Life Science San Diego, California www.nanocellect.com NanoCellect Biomedical is a developer of microfluidic cell sorting technologies for the biotech industry. NanoCellect Biomedical was founded in 2009 and is based in San Diego, California. |
Venture |
Anzu Partners
|
- | ||
| 2017-11-27 |
Medeor Therapeutics
Life Science San Mateo, California www.medeortherapeutics.com Medeor Therapeutics is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of personalized cellular immunotherapies to improve outcomes in organ transplant recipients. Medeor Therapeutics was founded in 2012 and is based in San Mateo, California. |
Venture |
Vivo Capital
|
- | ||
| 2017-11-15 |
Outpost Medicine
Life Science Indianapolis, Indiana www.outpostmedicine.com Outpost Medicine is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for the treatment of urologic and gastrointestinal disorders. Outpost Medicine was founded in 2016 and is based in Indianapolis, Indiana. |
Venture |
Vivo Capital
Frazier Healthcare Partners
Adams Street Partners
|
- | ||
| 2017-11-07 |
Biora Therapeutics
Life Science San Diego, California www.bioratherapeutics.com Biora Therapeutics is a clinical-stage biotechnology company developing oral therapeutic-delivery platforms for needle-free systemic delivery of large molecules and targeted therapy delivery in the gastrointestinal tract. Biora Therapeutics was founded in 2010 and is based in San Diego, California. |
Venture |
Athyrium Capital Management
|
- | ||
| 2017-10-24 |
Y-mAbs Therapeutics
Life Science Princeton, New Jersey www.ymabs.com Y-mAbs Therapeutics is a commercial-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. With a broad and advanced product pipeline, including pivotal-stage product candidates against a range of targets. Y-mAbs Therapeutics was founded in 2015 and is based in Princeton, New Jersey. |
Venture |
HBM Partners
|
- | ||
| Deal Article Deal Link | ||||||
| 2017-10-16 |
Antabio
Life Science Labege, France www.antabio.com Antabio is a biopharmaceutical company dedicated to the development of new treatments against antibiotic-resistant infections. Antabio was founded in 2009 and is based in Labege, France. |
Venture |
Ixo Private Equity
|
- | ||
| Deal Article Deal Link | ||||||
| 2017-10-13 |
InflaRx
Life Science Jena, Germany www.inflarx.de InflaRx is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. C5a is a powerful inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. The company is also developing additional molecules targeting chronic and inflammation-related diseases. InflaRx was founded in 2007 and is based in Jena, Germany. |
Venture |
Bain Capital Private Equity
|
- | ||
| Deal Article Deal Link | ||||||
| 2017-10-06 |
Harmony
Life Science Plymouth Meeting, Pennsylvania www.harmonybiosciences.com Harmony is a biopharmaceutical company developing and commercializing innovative drugs to address unmet needs for patients with sleep and CNS disorders. Harmony was founded in 2017 and is based in Plymouth Meeting, Pennsylvania. |
Venture |
Vivo Capital
Aisling Capital
HBM Partners
|
- | ||
| Avg |
$0.0
0.0x EBITDA 0.0x REVENUE |
|||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr was built to simplify the process of tracking who’s buying, selling, and what deals are happening across the private markets.
Behind every transaction is an opportunity, and Mergr gives professionals access to thousands of M&A deals, along with the investors, buyers, and sellers behind them.
The platform is powerful but easy to use — so you can quickly surface relevant transactions and move from research to action.
Full access to Mergr's investor, acquirer, and transaction data starts here.
